Enhanced Point-of-Care SARS-CoV-2 Detection: Integrating RT-LAMP with Microscanning.

Area of Science:

• Molecular Biology
• Biotechnology
• Infectious Disease Diagnostics

Background:

• The COVID-19 pandemic necessitates rapid and accurate diagnostic tools for SARS-CoV-2.
• Traditional RT-PCR methods are effective but require specialized equipment and trained personnel.
• There is a need for accessible, point-of-care diagnostic solutions.

Purpose of the Study:

• To develop and evaluate an integrated RT-LAMP-MS assay for SARS-CoV-2 detection.
• To assess the sensitivity, specificity, and limit of detection of the novel assay.
• To determine the suitability of the assay for resource-limited settings.

Main Methods:

• An integrated reverse transcription loop-mediated isothermal amplification (RT-LAMP) and microscanning (MS) assay was developed.
• Magnesium pyrophosphate, a byproduct of LAMP, was used as a visual marker for detection via microscopy.
• The assay was tested using clinical samples, with results compared to RT-LAMP and commercial assays.

Main Results:

• The RT-LAMP-MS assay demonstrated 99% sensitivity and 100% specificity in clinical tests.
• The limit of detection (LOD) was 10⁻¹ PFU mL⁻¹, with a dynamic range of 10³~10⁻¹ PFU mL⁻¹.
• The assay produced results within 30 minutes, showed 100% reproducibility, and utilized low-cost equipment.

Conclusions:

• The integrated RT-LAMP-MS assay provides a rapid, sensitive, and specific method for SARS-CoV-2 detection.
• Its low-cost nature and ease of use make it ideal for point-of-care applications, especially in resource-limited environments.
• This assay represents a significant advancement in accessible infectious disease diagnostics.